Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preemptive Intravenous Nefopam in Multimodal Analgesia for Total Knee Arthroplasty
TCTR20251224005Phase 3Active, not recruiting
- Sponsor
- Buddhachinaraj Phitsanulok Hospital
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of nefopam in postoperative pain (2 arms), sponsored by Buddhachinaraj Phitsanulok Hospital. Started Oct 2025; status: active, not recruiting.
02
Drugs
nefopam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on TCTR20251224005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251224005.